BIO-GATE AG (BIG1.DE) Stock Price, Forecast & Analysis
FRA:BIG1 • DE000BGAG981
BIG1.DE Key Statistics, Chart & Performance
The current stock price of BIG1.DE is 0.565 EUR. In the past month the price decreased by -28.03%. In the past year, price decreased by -9.6%.
BIG1.DE Technical Analysis
BIG1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BIG1.DE. While BIG1.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.
BIG1.DE Financial Highlights
Over the last trailing twelve months BIG1.DE reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 31.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.97% | ||
| ROE | -151.1% | ||
| Debt/Equity | 0 |
BIG1.DE Forecast & Estimates
8 analysts have analysed BIG1.DE and the average price target is 3.06 EUR. This implies a price increase of 441.59% is expected in the next year compared to the current price of 0.565.
For the next year, analysts expect an EPS growth of 30.3% and a revenue growth 0.33% for BIG1.DE
BIG1.DE Ownership
BIG1.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SY1 | SYMRISE AG | 18.62 | 10.474B | ||
| AKZA | AKZO NOBEL N.V. | 13.75 | 10.348B | ||
| SYENS | SYENSQO SA | 14.81 | 8.139B | ||
| EVK | EVONIK INDUSTRIES AG | 12.9 | 7.125B | ||
| UMI | UMICORE | 13.09 | 4.61B | ||
| NVJP | UMICORE | 13.26 | 4.586B | ||
| AKE | ARKEMA | 12.03 | 4.564B | ||
| WCH | WACKER CHEMIE AG | 121.22 | 4.081B | ||
| RBT | ROBERTET SA | 17.45 | 1.905B | ||
| ACT | ALZCHEM GROUP AG | 24.3 | 1.576B |
Related stock screener links
View all stocks in the Specialty Chemicals Industry | View all stocks in the Materials Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About BIG1.DE
Company Profile
Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern and currently employs 46 full-time employees. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
Company Info
BIO-GATE AG
Neumeyerstrasse 28-34
Nuremberg BAYERN DE
Employees: 46
Phone: 49911477523100
BIO-GATE AG / BIG1.DE FAQ
What does BIG1 do?
Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern and currently employs 46 full-time employees. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.
What is the current price of BIG1 stock?
The current stock price of BIG1.DE is 0.565 EUR. The price increased by 0.89% in the last trading session.
Does BIO-GATE AG pay dividends?
BIG1.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of BIG1 stock?
BIG1.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is BIO-GATE AG (BIG1.DE) stock traded?
BIG1.DE stock is listed on the Frankfurt Stock Exchange exchange.
Can you provide the market cap for BIO-GATE AG?
BIO-GATE AG (BIG1.DE) has a market capitalization of 5.22M EUR. This makes BIG1.DE a Nano Cap stock.
Who owns BIO-GATE AG?
You can find the ownership structure of BIO-GATE AG (BIG1.DE) on the Ownership tab.